This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Reviews
  • Journal Reviews
  • Resveratrol protects against steroid induced intraocular pressure

Resveratrol protects against steroid induced intraocular pressure
Reviewed by Graham Wallace

1 April 2016 | Graham Wallace | EYE - General | Glaucoma, Intraocular pressure, Resveratrol, Retina, Steroid-induced, Trabecular meshwork

Topical and systemic steroid delivery is a very effective treatment for many ocular conditions but is compromised by raised intraocular pressure which in turn leads to death of retinal ganglion cells and irreversible blindness. This is an important consideration with intraocular steroid release devices. Steroid-induced hypertension is associated with increased extracellular matrix deposition in the trabecular meshwork inhibiting outflow of aqueous humour. Resveratrol is a polyphenol found in grapes, wine and other plants. It has been linked to protective effects in heart disease and diabetes, and extending lifespan, due to antioxidant properties, although evidence in humans is not yet available. Previous studies by the authors have shown that a single topical treatment of trans-resveratrol in rats with steroid induced ocular hypertension (SIOH) reduced ocular hypertension. This was shown to be due to activation of adenosine A1 receptors and possible matrixmetalloproeinase-2 activity. In this study, trans-resveratrol topical administration was given twice daily, bilaterally to rats with or without SIOH. Treatment with trans-resveratrol significantly reduced IOP in animals with SIOH, associated with increased aqueous humour MMP-2 levels. TM thickness and cell number was reduced in treated animals, and the ganglion cell layer and inner retinal thickness were significantly increased. Finally, retinal oxidative stress was significantly decreased by treatment. These results support the use of trans-resveratrol in SIOH with positive effects on both the anterior and posterior segments of the eye. 

Topical trans-resveratrol ameliorates steroid-induced anterior and posterior segment changes in rats.
Razali N, Agarwal R, Agarwal P, et al.
EXPERIMENTAL EYE RESEARCH
2016;143:9-16.
Share This
CONTRIBUTOR
Graham Wallace

Birmingham and Midland Eye Centre, Birmingham, UK.

View Full Profile
Specialty
  • EYE - Cataract
  • EYE - Cornea
  • EYE - General
  • EYE - Glaucoma
  • EYE - Neuro-ophthalmology
  • EYE - Oculoplastic
  • EYE - Oncology
  • EYE - Orbit
  • EYE - Paediatrics
  • EYE - Pathology
  • EYE - Refractive
  • EYE - Strabismus
  • EYE - Vitreo-Retinal
Archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency